Patents by Inventor Scott MOERDLER

Scott MOERDLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KIR3DL3 is an inhibitory receptor of the immune system and uses thereof
    Patent number: 12534527
    Abstract: Described herein are antibodies, immunogenic fragments and compositions thereof targeting the killer-cell immunoglobulin-like receptor protein KIR3DL3, as well as methods of using the same for the treatment of human diseases including cancer. In certain embodiments, the disclosure relates to an antibody or an immunogenic fragment thereof that specifically binds to KIR3DL3 protein, wherein the antibody or the immunogenic fragment thereof specifically binds to a KIR3DL3 epitope comprising the whole extracellular domain or a portion thereof.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: January 27, 2026
    Assignee: Albert Einstein College of Medicine
    Inventors: Xingxing Zang, Yao Wei, Xiaoxin Ren, Scott Moerdler
  • KIR3DL3 IS AN INHIBITORY RECEPTOR OF THE IMMUNE SYSTEM AND USES THEREOF
    Publication number: 20230040568
    Abstract: Described herein are antibodies, immunogenic fragments and compositions thereof targeting the killer-cell immunoglobulin-like receptor protein KIR3DL3, as well as methods of using the same for the treatment of human diseases including cancer. In certain embodiments, the disclosure relates to an antibody or an immunogenic fragment thereof that specifically binds to KIR3DL3 protein, wherein the antibody or the immunogenic fragment thereof specifically binds to a KIR3DL3 epitope comprising the whole extracellular domain or a portion thereof.
    Type: Application
    Filed: October 1, 2020
    Publication date: February 9, 2023
    Inventors: Xingxing ZANG, Yao WEI, Xiaoxin REN, Scott MOERDLER